ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,208.00
      0.23%
      Dow Jones
      39,118.86
      0.00%
      Brent Oil
      85.445
      0.39%
      Bitcoin
      62,678.57
      0.13%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. NGM Biopharmaceuticals Inc (NGM)

      7. NGM Biopharmaceuticals Inc (NGM) News

      NGM

      NGM Biopharmaceuticals (NGM)

      NGM Biopharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:NGM
      DateTimeSourceHeadlineSymbolCompany
      05/19/20224:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NGMNGM Biopharmaceuticals Inc
      05/19/20224:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NGMNGM Biopharmaceuticals Inc
      05/17/20224:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NGMNGM Biopharmaceuticals Inc
      05/17/20224:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NGMNGM Biopharmaceuticals Inc
      05/13/20225:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NGMNGM Biopharmaceuticals Inc
      05/13/20225:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NGMNGM Biopharmaceuticals Inc
      05/12/20228:00AMGlobeNewswire Inc.NGM Bio Announces Initiation of Phase 1/1b Clinical Study of NGM438 for the Treatment of Patients with Advanced Solid TumorsNASDAQ:NGMNGM Biopharmaceuticals Inc
      05/12/20227:35AMTipRanksNGM Biopharmaceuticals (NGM) Receives a Buy from B.Riley FinancialNASDAQ:NGMNGM Biopharmaceuticals Inc
      05/11/20226:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NGMNGM Biopharmaceuticals Inc
      05/11/20226:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NGMNGM Biopharmaceuticals Inc
      05/05/20224:39PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NGMNGM Biopharmaceuticals Inc
      05/05/20224:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NGMNGM Biopharmaceuticals Inc
      05/05/20224:14PMGlobeNewswire Inc.NGM Bio Provides Business Highlights and Reports First Quarter 2022 Financial ResultsNASDAQ:NGMNGM Biopharmaceuticals Inc
      04/20/20224:05PMGlobeNewswire Inc.NGM Bio to Participate in Upcoming Investor ConferencesNASDAQ:NGMNGM Biopharmaceuticals Inc
      04/20/20229:00AMGlobeNewswire Inc.NGM Bio to Host the Second of Four Virtual R&D Events on April 27, 2022NASDAQ:NGMNGM Biopharmaceuticals Inc
      04/08/20228:00AMGlobeNewswire Inc.NGM Bio to Present Late-Breaking Preclinical Research at 2022 AACR Annual Meeting Supporting Development of its Myeloid Reprogramming PortfolioNASDAQ:NGMNGM Biopharmaceuticals Inc
      04/06/20224:14PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NGMNGM Biopharmaceuticals Inc
      03/31/20224:05PMGlobeNewswire Inc.NGM Bio Announces Initiation of Phase 1/1b Clinical Trial of NGM831 for the Treatment of Patients with Advanced Solid TumorsNASDAQ:NGMNGM Biopharmaceuticals Inc
      03/21/20228:00AMGlobeNewswire Inc.NGM Bio to Host the First of Four Virtual R&D Events on March 30, 2022NASDAQ:NGMNGM Biopharmaceuticals Inc
      03/17/20223:25PMTipRanksB.Riley Financial Thinks NGM Biopharmaceuticals’ Stock is Going to RecoverNASDAQ:NGMNGM Biopharmaceuticals Inc
      03/10/20225:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NGMNGM Biopharmaceuticals Inc
      03/08/20224:13PMGlobeNewswire Inc.NGM Bio Announces Oral and Late-Breaking Poster Presentations Supporting Its Myeloid Reprogramming Portfolio at Upcoming 2022 AACR Annual MeetingNASDAQ:NGMNGM Biopharmaceuticals Inc
      03/04/20224:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NGMNGM Biopharmaceuticals Inc
      03/04/20224:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NGMNGM Biopharmaceuticals Inc
      03/04/20222:46AMTipRanksNGM Biopharmaceuticals (NGM) Receives a Buy from B.Riley FinancialNASDAQ:NGMNGM Biopharmaceuticals Inc
      03/01/20224:41PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:NGMNGM Biopharmaceuticals Inc
      03/01/20224:21PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NGMNGM Biopharmaceuticals Inc
      03/01/20224:06PMGlobeNewswire Inc.NGM Bio Provides Business Highlights and Reports Fourth Quarter and Full Year 2021 Financial ResultsNASDAQ:NGMNGM Biopharmaceuticals Inc
      02/28/20228:00AMGlobeNewswire Inc.NGM Bio to Participate in the Cowen 42nd Annual Health Care ConferenceNASDAQ:NGMNGM Biopharmaceuticals Inc
      02/07/20228:00AMGlobeNewswire Inc.NGM Bio’s NGM621 Receives Fast Track Designation from the FDA for the Treatment of Patients with Geographic Atrophy Secondary to Age-Related Macular DegenerationNASDAQ:NGMNGM Biopharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:NGM

      Your Recent History

      BIT
      UB3CW2
      Unicredit Bank
      Delayed Upgrade Clock